Treatment of Low Bone Density or Osteoporosis to Prevent Fractures
暂无分享,去创建一个
[1] Efstathios D. Gennatas,et al. Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity , 2021, The Lancet Infectious Diseases.
[2] H. Ullum,et al. Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers , 2020, Annals of Internal Medicine.
[3] G. Schoch,et al. Incidence, Risk Factors, and Outcomes of Idiopathic Pneumonia Syndrome after Allogeneic Hematopoietic Cell Transplantation , 2019, Biology of Blood and Marrow Transplantation.
[4] Yoshihiro Sato. Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in stroke patients , 2016, Neurology.
[5] L. Wilkins. Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease , 2016, Neurology.
[6] James Y. Dai,et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. , 2015, The New England journal of medicine.
[7] Enola K Proctor,et al. Implementation strategies: recommendations for specifying and reporting , 2013, Implementation Science.
[8] Katrien Fransen,et al. Preexposure prophylaxis for HIV infection among African women. , 2012, The New England journal of medicine.
[9] P. Shekelle,et al. Pharmacologic Treatment of Low Bone Density or Osteoporosis to Prevent Fractures: A Clinical Practice Guideline from the American College of Physicians , 2008, Annals of Internal Medicine.
[10] E. Warburton,et al. Risedronate therapy for prevention of hip fracture after stroke in elderly women , 2005, Neurology.
[11] J. Iwamoto,et al. Low-Dose Vitamin D Prevents Muscular Atrophy and Reduces Falls and Hip Fractures in Women after Stroke: A Randomized Controlled Trial , 2005, Cerebrovascular Diseases.
[12] J. Iwamoto,et al. The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. , 2005, Archives of internal medicine.
[13] J. Iwamoto,et al. Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. , 2005, Archives of internal medicine.
[14] J. Iwamoto,et al. Beneficial Effect of Etidronate Therapy in Immobilized Hip Fracture Patients[Retracted] , 2004, American journal of physical medicine & rehabilitation.
[15] Yoshihiro Sato,et al. Beneficial Effect of Intermittent Cyclical Etidronate Therapy in Hemiplegic Patients Following an Acute Stroke , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] K. Oizumi,et al. Effect of ipriflavone on bone in elderly hemiplegic stroke patients with hypovitaminosis D. , 1999, American journal of physical medicine & rehabilitation.
[17] Yoshihiro Sato,et al. Amelioration of osteopenia and hypovitaminosis D by 1α-hydroxyvitamin D3 in elderly patients with Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.
[18] T. Gross,et al. For Personal Use. Only Reproduce with Permission from Elsevier Ltd Public Health Inequalities in Health between and within Countries: Poverty and Inequality Social Determinants of Health Inequalities , 2022 .